Literature DB >> 8053050

Is the transjugular intrahepatic portocaval shunt procedure beneficial for liver transplant recipients?

R B Freeman1, S E FitzMaurice, A E Greenfield, N Halin, C E Haug, R J Rohrer.   

Abstract

Recent reports document the efficacy of transjugular intrahepatic portocaval shunts (TIPS) for the prevention of portal hypertensive bleeding and have advocated its use as a bridge to liver transplantation. There are no reports, however, analyzing liver transplant results for patients with indwelling TIPS. We reviewed the records of all adult primary recipients with a history of portal hypertensive bleeding or unmanageable ascites transplanted since the TIPS procedure became available in our institution in July 1991. Seven of 20 recipients underwent TIPS before transplant. There were no significant differences between patients with or without TIPS in age, United Network for Organ Sharing status, Child-Pugh score, preoperative prothrombin time, operative time, operative blood product requirement, overall length of stay, and 6-month patient survival after transplant. We noted a trend toward less operative red cell (26.0 +/- 26.2 vs. 31.8 +/- 38.1 U, mean +/- SD) and autologous blood (4,762 +/- 3,335 vs. 13,355 [corrected] +/- 20,460 ml) transfusion and improved patient survival for those with a TIPS. Patients with a TIPS in place waited significantly longer for their transplant (282 +/- 113 vs. 149 +/- 113 days, P = 0.014). There were 2 technical complications related to the TIPS, 1 in a patient who died after rupture of the suprahepatic vena caval anastomosis where the device had traversed the caval/hepatic vein junction and weakened the tissues, and the other in a survivor in whom the device extended into the right atrium and was extracted during the transplant procedure. Three patients with TIPS in place died of sepsis while waiting for a donor organ. We conclude that while the TIPS offers benefits for the liver transplant recipient, placement of the device in small shrunken cirrhotic livers must be precise. Immediate benefits for the transplant candidate may be offset by increased waiting time and technical complications at the transplant operation.

Entities:  

Mesh:

Year:  1994        PMID: 8053050

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

Review 2.  Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

3.  Gastrointestinal bleeding after liver transplantation.

Authors:  J Tabasco-Minguillán; A Jain; M Naik; K M Weber; W Irish; J J Fung; J Rakela; T E Starzl
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

Review 4.  Liver transplantation complicated by misplaced TIPS in the portal vein.

Authors:  P A Clavien; M Selzner; J E Tuttle-Newhall; R C Harland; P Suhocki
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

5.  Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database.

Authors:  Khalid Mumtaz; Sherif Metwally; Rohan M Modi; Nishi Patel; Dmitry Tumin; Anthony J Michaels; James Hanje; Ashraf El-Hinnawi; Don Hayes; Sylvester M Black
Journal:  World J Hepatol       Date:  2017-01-18

Review 6.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12

Review 7.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.